Table: begin end state 1 19 cytoplasmic 20 39 transmembrane 40 50 non-cytoplasmic 51 76 transmembrane 77 87 cytoplasmic 88 111 transmembrane 112 116 non-cytoplasmic 117 118 transmembrane 119 122 non-cytoplasmic 123 142 transmembrane 143 153 cytoplasmic 154 175 transmembrane 176 186 non-cytoplasmic 187 206 transmembrane 207 237 cytoplasmic 238 256 transmembrane 257 275 non-cytoplasmic 276 295 transmembrane 296 304 cytoplasmic 305 326 transmembrane 327 337 non-cytoplasmic 338 358 transmembrane 359 367 cytoplasmic 368 390 transmembrane 391 401 non-cytoplasmic 402 419 transmembrane 420 432 cytoplasmic
Input: >HSERO_RS07330 MTTTTTNAKHSKLSTVLRVTSGNFLEMFDFFLYGFYASYISKTFFPSDNEFVSLILTFGT FGAGFLMRPLGAIILGSYIDRVGRRQGLIVTLAIMAIGTLLIAFVPGYATIGVAAPILVL TGRLLQGFSAGVELGGVSVYLAEMATPGNKGFYVSWQSASQQAAIMASALIGYLVSQSLS PVQISDWGWRIPFFIGCMIVPAIFIIRRSLQETDEFLARKRHPSFGEIMSSIAQNWKIVV AGMMMVVMTTVSFYLITVYTPTFGKNVLKLSASDSLIVTFCVGLSNFCWLPIMGALSDRV GRRPVLVAFTLLTLLTAYPVMSWLVSDISFKNLLITELWLSFLYASYNGAAVVALTEVMP AHVRTVGFSLAYSLATAIFGGFTPLVSTWLIETSGDKAAPGYWMSFAAVCGLLATLVLYR GKSAAATVSPTA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server